PRFX 0.98 (-10.91%)
IL0011651580Drug ManufacturersDrug Manufacturers - Specialty & Generic

PainReform (PRFX) Competitor Comparison

We are evaluating the key criteria listed to compare PainReform (PRFX) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Performance 10 years - PRFX ranking 0 / 55

These are the competitors of PainReform in the industry Drug Manufacturers - Specialty & Generic ranked by performance 10 years
1. Amphastar Pharmaceuticals AMPH
466
2. Zoetis ZTS
426.62
3. Supernus Pharmaceuticals SUPN
278
4. ProPhase Labs PRPH
248.66
5. Collegium Pharmaceutical COLL
197.58
6. Catalent CTLT
181.5
7. ANI Pharmaceuticals ANIP
156.15
8. Harrow Health HROW
74.97
9. Vifor Pharma G2AB.F
39.09
10. Kolinpharma KIP.MI
36.65
11. Alvotech ALVO
28.84
12. Avadel Pharmaceuticals AVDL
25.41
13. Evolus EOLS
7.47
14. Ironwood Pharmaceuticals IRWD
-5.15
15. Theratechnologies THTX
-6.58
16. PetIQ PETQ
-21.62
17. Phibro Animal Health PAHC
-21.68
18. Alimera Sciences ALIM
-21.78
19. Curaleaf Holdings CURLF
-39.21
20. Linc LNC
-39.24
21. Journey Medical DERM
-49.2
22. Elanco Animal Health ELAN
-55.5
23. Green Thumb Industries R9U2.F
-56.49
24. Taro Pharmaceutical Industries TARO
-59.87
25. Pacira BioSciences PCRX
-59.88
26. Eagle Pharmaceuticals EGRX
-61.75
27. Cumberland Pharmaceuticals CPIX
-63.62
28. Kamada KMDA
-64.11
29. Clever Leaves Holdings CLVR
-64.61
30. Ayr Wellness 3KJB.F
-67.04
31. Amneal Pharmaceuticals AMRX
-67.53
32. Regencell Bioscience Holdings RGC
-68.25
33. Cronos Group CRON
-69.54
34. Organogenesis Holdings ORGO
-70.76
35. Procaps Group PROC
-72.69
36. Teva Pharmaceutical Industries TEVA
-73.43
37. Perrigo PRGO
-78.42
38. Embecta EMBC
-78.65
39. Jupiter Wellness JUPW
-80
40. Societal CDMO SCTL
-82.48
41. Ascend Wellness Holdings AAWH
-87.24
42. Alpha Teknova TKNO
-88.37
43. Emergent BioSolutions EBS
-91.21
44. Tilray Brands TLRY
-92.1
45. Relmada Therapeutics RLMD
-92.25
46. Bausch Health Companies BHC
-92.73
47. Zynerba Pharmaceuticals ZYNE
-92.78
48. OptiNose OPTN
-93.9
49. Neoleukin Therapeutics NLTX
-94.08
50. Universe Pharmaceuticals UPC
-94.55
51. Solid Biosciences SLDB
-97.29
52. Biofrontera BFRI
-97.44
53. Flora Growth FLGC
-98.2
54. SCYNEXIS SCYX
-98.51
55. MedAvail Holdings MDVL
-100

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.